- ►diabetesjournals.org Y Zhang, BV Howard, LD Cowan, J Yeh, CF … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—This report is based on 857 women who were both
nondiabetic and postmenopausal at the baseline examination (1989–1992) and who
completed a second examination (1993–1995) an average of 4 years later. ... Cited by 36 - Related articles - BL Direct - All 5 versions
RJ TROISI, CC Cowie, MI Harris - Obstetrics & Gynecology, 2000 - journals.lww.com Cited Here...: Cross-sectional data from the third National Health and Nutrition
Examination Survey (1988-1994) included levels of hemoglobin A 1c in women with
diagnosed diabetes and levels of hemoglobin A 1c , fasting and 2-hour ... Cited by 35 - Related articles - BL Direct - All 4 versions
- ►ajph.org [PDF] LL Gabal, D Goodman-Gruen, E Barrett- … - American Journal of Public Health, 1997 - Am Public Health Assoc In every country and at every age, women are at lower risk for coronary heart
disease than men.1-5 This has led to the hypothesis that estrogen is cardiopro-
tective. Despite the increased use of postmenopausal estrogen replacement ... Cited by 44 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org AS Ryan, BJ Nicklas, DM Berman - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Vo 2max (maximal aerobic capacity), percentage of fat, total body fat
mass, and fat-free mass (FFM) were similar between groups. Visceral fat,
subcutaneous abdominal fat, sagittal diameter, and mid-thigh low-density ... Cited by 54 - Related articles - BL Direct - All 8 versions
- ►gva.es [PDF] - Free from Publisher R Rossi, G Origliani, MG Modena - Diabetes Care, 2004 - Am Diabetes Assoc OBJECTIVE—Various observational and randomized studies have demonstrated a
reduction in the incidence of type 2 diabetes in postmenopausal women who
received estrogen orally. No studies have been performed on the incidence ... Cited by 27 - Related articles - BL Direct - All 6 versions
JE Manson, EB Rimm, GA Colditz, WC Willett … - Annals of epidemiology, 1992 - ncbi.nlm.nih.gov The potential influence of postmenopausal estrogen therapy on the subsequent
development of non-insulin-dependent diabetes mellitus (NIDDM) is relatively
unexplored, despite postulated effects of these hormones on glucose ... Cited by 92 - Related articles - All 2 versions
- ►diabetesjournals.org [PDF] MA Espeland, PE Hogan, SE Fineberg, G … - Diabetes Care, 1998 - Am Diabetes Assoc F rom the Wake Forest University School of Medicine (MAE, PEH, GH),
Winston-Salem, North Caro lina ; the Indiana University School of Medicine
(SEF), Indianapolis, Indiana; the University of Iowa Lipid R esea rch ... Cited by 114 - Related articles - BL Direct - All 8 versions
N Colacurci, R Zarcone, A Mollo, G Russo, M … - Panminerva medica, 1998 - ncbi.nlm.nih.gov OBJECTIVE: To evaluate the relationship between hormone replacement therapy and
glucose metabolism, and the possible role played by the administration route.
DESIGN: Prospective randomized study. MATERIALS AND METHODS: Eighty-four ... Cited by 25 - Related articles - BL Direct - All 3 versions
- ►annals.org AM Kanaya, D Herrington, E Vittinghoff, F Lin, … - Annals of internal medicine, 2003 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Randomized trials of postmenopausal hormone therapy have found ... Cited by 193 - Related articles - BL Direct - All 7 versions
SI Wu, P Chou, ST Tsai - Journal of clinical epidemiology, 2001 - Elsevier This is a community-based population survey carried out by the Yang-Ming Crusade
to investigate the impact of years since menopause on the development of glucose
intolerance in post-menopausal women. A total of 5412 women were screened ... Cited by 30 - Related articles - BL Direct - All 8 versions
